8-aminoquinoline has been researched along with Malaria, Vivax in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 7 (46.67) | 2.80 |
| Authors | Studies |
|---|---|
| Andolina, C; Awuku, NA; Bifani, P; Campo, B; Chaumeau, V; Chhin, C; Chua, ACY; Conway, AJ; Cooper, CA; Doeurk, B; Jiang, RHY; Kim, S; Kittiphanakun, P; Kyle, DE; Maher, SP; Nosten, F; Ouk, S; Péneau, J; Phal, S; Phen, S; Piv, E; Rizopoulos, Z; Rouillier, M; Russell, B; Suriyakan, S; Tat, B; Vantaux, A; Vong, C; Witkowski, B | 1 |
| Flaherty, S; Maktabi, M; Pybus, BS; Reichard, G; Rochford, R; Strauch, P; Walker, LA | 1 |
| Boonyuen, U; Chamchoy, K; Krudsood, S; Patrapuvich, R; Sudsumrit, S; Thita, T | 1 |
| Bancone, G; Brummaier, T; Chotivanich, K; Chu, CS; Gilder, ME; Gornsawun, G; McGready, R; Nosten, F; Pimanpanarak, M | 1 |
| Alam, MS; Ami, JQ; Auburn, S; Hossain, MS; Jahan, N; Johora, FT; Khan, WA; Kibria, MG; Koepfli, C; Ley, B; Phru, CS; Price, RN; Thriemer, K | 1 |
| Burke, PA; Chavas, TEJ; Flaherty, SM; Ho, DK; Huber, HE; Jackson, C; LeGuyader, CLM; Li, Q; Lin, H; Maktabi, M; Pottenger, A; Pybus, B; Rochford, R; Roy, D; Srinivasan, S; Stayton, PS; Strauch, P; Vlaskin, V; Wesche, D; Zhang, J | 1 |
| Advani, N; Bansil, P; Brito, M; Clementino Freitas, S; Domingo, GJ; Garbin, E; Gerth-Guyette, E; Kahn, M; Lacerda, MV; Macedo, M; Monteiro, WM; Pal, S; Pereira, D; Soares Moura, A; Zobrist, S | 1 |
| Advani, N; Cohen, J; Domingo, GJ; Kalnoky, M; Kelley, M; Parker, M; Rowley, E; Satyagraha, AW; Sibley, CH | 1 |
| Auburn, S; Baird, K; Bancone, G; Cheng, Q; Domingo, G; Espino, F; Green, J; Howes, R; McCarthy, J; Ménard, D; Moyes, C; Price, R; Shanks, D; Vestergaard, LS; von Seidlein, L; Winasti-Satyahraha, A; Yeung, S | 1 |
| Bansil, P; Domingo, GJ; Huang, H; Jiang, H; Kahn, M; Kalnoky, M; LaRue, N; Leader, BT; McGray, S; Murray, M; Zhang, H | 1 |
| Bancone, G; Bansil, P; Charunwatthana, P; Chowwiwat, N; Chu, CS; Domingo, GJ; McGray, S; Nosten, FH; Somsakchaicharoen, R; Wilaisrisak, P | 1 |
| Burrows, JN; Campo, B; Vandal, O; Wesche, DL | 1 |
| CRAIGE, B; JONES, R | 1 |
| ALVING, AS; BREWER, GJ; CARSON, PE; JOHNSON, CF; KELLERMEYER, RW; TARLOV, AR | 1 |
| LYSENKO, AY | 1 |
2 review(s) available for 8-aminoquinoline and Malaria, Vivax
| Article | Year |
|---|---|
Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report.
Topics: Aminoquinolines; Clinical Laboratory Techniques; Drug-Related Side Effects and Adverse Reactions; Glucosephosphate Dehydrogenase Deficiency; Humans; Korea; Malaria, Falciparum; Malaria, Vivax | 2013 |
Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax.
Topics: Aminoquinolines; Antimalarials; Chemical and Drug Induced Liver Injury; Disease Eradication; Drug Discovery; Humans; Liver; Malaria, Vivax; Plasmodium vivax; Recurrence; Sporozoites | 2015 |
13 other study(ies) available for 8-aminoquinoline and Malaria, Vivax
| Article | Year |
|---|---|
Probing the distinct chemosensitivity of Plasmodium vivax liver stage parasites and demonstration of 8-aminoquinoline radical cure activity in vitro.
Topics: Aminoquinolines; Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Drug Discovery; Drug Synergism; Humans; Life Cycle Stages; Liver; Malaria, Vivax; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium vivax; ROC Curve; Time Factors | 2021 |
Mechanisms of 8-aminoquinoline induced haemolytic toxicity in a G6PDd humanized mouse model.
Topics: Aminoquinolines; Animals; Antimalarials; Disease Models, Animal; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Malaria, Vivax; Mice; Primaquine | 2022 |
Cytochrome P450 2D6 (CYP2D6) and glucose-6-phosphate dehydrogenase (G6PD) genetic variations in Thai vivax malaria patients: Implications for 8-aminoquinoline radical cure.
Topics: Antimalarials; Cytochrome P-450 CYP2D6; Genetic Variation; Glucosephosphate Dehydrogenase; Hemolysis; Humans; Malaria; Malaria, Vivax; Primaquine; Southeast Asian People | 2022 |
Vivax malaria in pregnancy and lactation: a long way to health equity.
Topics: Adolescent; Aminoquinolines; Anemia; Antimalarials; Artemether, Lumefantrine Drug Combination; Female; Fetal Growth Retardation; Glucosephosphate Dehydrogenase Deficiency; Health Equity; Humans; Infant, Small for Gestational Age; Lactation Disorders; Malaria, Vivax; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Primaquine | 2020 |
Wide range of G6PD activities found among ethnic groups of the Chittagong Hill Tracts, Bangladesh.
Topics: Adult; Aminoquinolines; Bangladesh; Diagnostic Tests, Routine; Ethnicity; Female; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Vivax; Male; Middle Aged; Polymerase Chain Reaction; Prevalence; Young Adult | 2020 |
Liver-targeted polymeric prodrugs of 8-aminoquinolines for malaria radical cure.
Topics: Aminoquinolines; Animals; Antimalarials; Liver; Malaria; Malaria, Vivax; Mice; Mice, Inbred NOD; Mice, SCID; Polymers; Primaquine; Prodrugs | 2021 |
Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antimalarials; Biosensing Techniques; Brazil; Child; Child, Preschool; Cross-Sectional Studies; Female; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Linear Models; Malaria, Vivax; Male; Middle Aged; Point-of-Care Testing; ROC Curve; Young Adult | 2021 |
Addressing the gender-knowledge gap in glucose-6-phosphate dehydrogenase deficiency: challenges and opportunities.
Topics: Africa; Aminoquinolines; Antimalarials; Female; Glucosephosphate Dehydrogenase Deficiency; Health Knowledge, Attitudes, Practice; Humans; Malaria, Vivax; Male; Primaquine; Risk Factors; Sex Factors | 2019 |
Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency.
Topics: Adult; Aminoquinolines; Antimalarials; Female; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Heterozygote; Humans; Malaria, Vivax; Male; Middle Aged; Plasmodium vivax; Sensitivity and Specificity; Young Adult | 2014 |
Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests.
Topics: Aminoquinolines; Antimalarials; Capillaries; Clinical Enzyme Tests; Erythrocytes; Female; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Vivax; Male; Point-of-Care Systems; Primaquine; Sensitivity and Specificity; Veins | 2015 |
A study of the prophylactic effectiveness of several 8-aminoquinolines in sporozoite-induced vivax malaria, Chesson strain.
Topics: Aminoquinolines; Animals; Humans; Malaria; Malaria, Vivax; Quinolines; Sporozoites | 1948 |
Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report.
Topics: Adult; Aminoquinolines; Antimalarials; Chloroquine; Hemolysis; Humans; Malaria, Vivax; Male; Primaquine | 1960 |
Use of quinocide in treatment and prophylaxis of vivax malaria.
Topics: Aminoquinolines; Antimalarials; Biomedical Research; Humans; Laboratories; Malaria; Malaria, Vivax; Male; Quinolines | 1960 |